Literature DB >> 32026204

Cardiovascular diseases in survivors of childhood cancer.

Neha Bansal1, Javier G Blanco2, Umesh C Sharma3, Saraswati Pokharel4, Shannon Shisler5, Steven E Lipshultz6,7,8,9,10.   

Abstract

Over the past few decades, the diagnosis and management of children with various malignancies have improved tremendously. As a result, there are an increasing number of children who are long-term cancer survivors. With improved survival, however, has come an increased risk of treatment-related cardiovascular complications that can appear decades after treatment. These problems are serious enough that all caregivers of childhood cancer survivors, including oncologists, cardiologists, and other health care personnel, must pay close attention to the short- and long-term effects of chemotherapy and radiotherapy on these children. This review discusses the effects of treatment-related cardiovascular complications from anthracyclines and radiotherapy and the methods for preventing, screening, and treating these complications.

Entities:  

Keywords:  Cardio-oncology; Cardiotoxicity; Chemotherapy; Radiotherapy; Survivorship

Mesh:

Substances:

Year:  2020        PMID: 32026204      PMCID: PMC7123498          DOI: 10.1007/s10555-020-09859-w

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  139 in total

Review 1.  Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials.

Authors:  Elvira C van Dalen; Marieke van den Brug; Huib N Caron; Leontien C M Kremer
Journal:  Eur J Cancer       Date:  2006-09-29       Impact factor: 9.162

2.  Adriamycin cardiotoxicity in man.

Authors:  J J Rinehart; R P Lewis; S P Balcerzak
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

Review 3.  Systems biology approaches to adverse drug effects: the example of cardio-oncology.

Authors:  Sherry-Ann Brown; Nicole Sandhu; Joerg Herrmann
Journal:  Nat Rev Clin Oncol       Date:  2015-10-13       Impact factor: 66.675

4.  Anthracycline cardiotoxicity: the importance of horizontally integrating pre-clinical and clinical research.

Authors:  Steven E Lipshultz; Eugene H Herman
Journal:  Cardiovasc Res       Date:  2018-02-01       Impact factor: 10.787

Review 5.  Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies.

Authors:  Karlijn A Wouters; Leontien C M Kremer; Tracie L Miller; Eugene H Herman; Steven E Lipshultz
Journal:  Br J Haematol       Date:  2005-12       Impact factor: 6.998

Review 6.  Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review.

Authors:  L C M Kremer; H J H van der Pal; M Offringa; E C van Dalen; P A Voûte
Journal:  Ann Oncol       Date:  2002-06       Impact factor: 32.976

7.  N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.

Authors:  Yun-He Liu; Martin D'Ambrosio; Tang-dong Liao; Hongmei Peng; Nour-Eddine Rhaleb; Umesh Sharma; Sabine André; Hans-J Gabius; Oscar A Carretero
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-19       Impact factor: 4.733

8.  Detection and monitoring of cardiotoxicity-what does modern cardiology offer?

Authors:  Ruxandra Jurcut; Hans Wildiers; Javier Ganame; Jan D'hooge; Robert Paridaens; Jens-Uwe Voigt
Journal:  Support Care Cancer       Date:  2008-01-16       Impact factor: 3.603

9.  Detection of late radiation damage on left atrial fibrosis using cardiac late gadolinium enhancement magnetic resonance imaging.

Authors:  Y Jessica Huang; Alexis Harrison; Vikren Sarkar; Prema Rassiah-Szegedi; Hui Zhao; Martin Szegedi; Long Huang; Brent Wilson; David K Gaffney; Bill J Salter
Journal:  Adv Radiat Oncol       Date:  2016-04-26

Review 10.  Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors.

Authors:  Neha Bansal; M Jacob Adams; Sarju Ganatra; Steven D Colan; Sanjeev Aggarwal; Rudolf Steiner; Shahnawaz Amdani; Emma R Lipshultz; Steven E Lipshultz
Journal:  Cardiooncology       Date:  2019-12-02
View more
  10 in total

Review 1.  Heart Failure with Preserved Ejection Fraction in Children.

Authors:  Bibhuti Das; Shriprasad Deshpande; Jyothsna Akam-Venkata; Divya Shakti; William Moskowitz; Steven E Lipshultz
Journal:  Pediatr Cardiol       Date:  2022-08-17       Impact factor: 1.838

Review 2.  Cardio-Oncology in Childhood: State of the Art.

Authors:  Elena Bennati; Francesca Girolami; Gaia Spaziani; Giovanni Battista Calabri; Claudio Favre; Iris Parrini; Fabiana Lucà; Angela Tamburini; Silvia Favilli
Journal:  Curr Oncol Rep       Date:  2022-10-01       Impact factor: 5.945

Review 3.  Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence.

Authors:  Ibrahim Y Abdelgawad; Karim T Sadak; Diana W Lone; Mohamed S Dabour; Laura J Niedernhofer; Beshay N Zordoky
Journal:  Pharmacol Ther       Date:  2020-12-01       Impact factor: 12.310

4.  Deleterious Effects of Hyperactivity of the Renin-Angiotensin System and Hypertension on the Course of Chemotherapy-Induced Heart Failure after Doxorubicin Administration: A Study in Ren-2 Transgenic Rat.

Authors:  Petr Kala; Hana Bartušková; Jan Piťha; Zdenka Vaňourková; Soňa Kikerlová; Šárka Jíchová; Vojtěch Melenovský; Lenka Hošková; Josef Veselka; Elzbieta Kompanowska-Jezierska; Janusz Sadowski; Olga Gawrys; Hana Maxová; Luděk Červenka
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923

5.  Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study.

Authors:  Adriana Linares Ballesteros; Roy Sanguino Lobo; Juan Camilo Villada Valencia; Oscar Arévalo Leal; Diana Constanza Plazas Hernández; Nelson Aponte Barrios; Iván Perdomo Ramírez
Journal:  Colomb Med (Cali)       Date:  2021-02-15

6.  Cardiovascular Health Status And Genetic Risk In Survivors of Childhood Neuroblastoma and Nephroblastoma Treated With Doxorubicin: Protocol of the Pharmacogenetic Part of the LESS-Anthra Cross-Sectional Cohort Study.

Authors:  Oliver Zolk; Annika von dem Knesebeck; Norbert Graf; Thorsten Simon; Barbara Hero; Hashim Abdul-Khaliq; Mohamed Abd El Rahman; Claudia Spix; Benjamin Mayer; Susanne Elsner; Judith Gebauer; Thorsten Langer
Journal:  JMIR Res Protoc       Date:  2022-02-17

7.  Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.

Authors:  Jutta Bergler-Klein; Peter P Rainer; Markus Wallner; Marc-Michael Zaruba; Jakob Dörler; Armin Böhmer; Tamara Buchacher; Maria Frey; Christopher Adlbrecht; Rupert Bartsch; Mariann Gyöngyösi; Ursula-Maria Fürst
Journal:  Wien Klin Wochenschr       Date:  2022-05-04       Impact factor: 2.275

Review 8.  The Role of Nutrition in Primary and Secondary Prevention of Cardiovascular Damage in Childhood Cancer Survivors.

Authors:  Fiorentina Guida; Riccardo Masetti; Laura Andreozzi; Daniele Zama; Marianna Fabi; Matteo Meli; Arcangelo Prete; Marcello Lanari
Journal:  Nutrients       Date:  2022-08-11       Impact factor: 6.706

Review 9.  Radiation-induced myocardial fibrosis: Mechanisms underlying its pathogenesis and therapeutic strategies.

Authors:  Bin Wang; Huanhuan Wang; Mengmeng Zhang; Rui Ji; Jinlong Wei; Ying Xin; Xin Jiang
Journal:  J Cell Mol Med       Date:  2020-06-14       Impact factor: 5.310

10.  Characterization of Cardiac, Vascular, and Metabolic Changes in Young Childhood Cancer Survivors.

Authors:  Olof Broberg; Ingrid Øra; Thomas Wiebe; Constance G Weismann; Petru Liuba
Journal:  Front Pediatr       Date:  2021-12-08       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.